GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » 111 Inc (NAS:YI) » Definitions » Debt-to-Revenue

111 (YI) Debt-to-Revenue : 0.03 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is 111 Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

111's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $53 Mil. 111's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $9 Mil. 111's annualized Revenue for the quarter that ended in Dec. 2023 was $2,302 Mil. 111's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.03.


111 Debt-to-Revenue Historical Data

The historical data trend for 111's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

111 Debt-to-Revenue Chart

111 Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial 0.05 0.04 0.04 0.03 0.03

111 Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.03 0.03 0.03

Competitive Comparison of 111's Debt-to-Revenue

For the Medical Distribution subindustry, 111's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


111's Debt-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, 111's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where 111's Debt-to-Revenue falls into.



111 Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

111's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(53.305 + 8.771) / 2093.517
=0.03

111's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(53.305 + 8.771) / 2301.688
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


111 Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of 111's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


111 (YI) Business Description

Traded in Other Exchanges
Address
No.295 ZuChongZhi Road, 3rd-5th Floors, Pudong New Area, Shanghai, CHN, 201203
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.